Role of the p66Shc Isoform in Insulin-like Growth Factor I Receptor Signaling through MEK/Erk and Regulation of Actin Cytoskeleton in Rat Myoblasts
Open Access
- 1 October 2004
- journal article
- Published by Elsevier
- Vol. 279 (42) , 43900-43909
- https://doi.org/10.1074/jbc.m403936200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- MEK Mediates v-Src-induced Disruption of the Actin Cytoskeleton via Inactivation of the Rho-ROCK-LIM Kinase PathwayJournal of Biological Chemistry, 2002
- The p66Shc Longevity Gene Is Silenced through Epigenetic Modifications of an Alternative PromoterJournal of Biological Chemistry, 2002
- Early Stimulation and Late Inhibition of Extracellular Signal-Regulated Kinase 1/2 Phosphorylation by IGF-I: A Potential Mechanism Mediating the Switch in IGF-I Action on Skeletal Muscle Cell DifferentiationEndocrinology, 2002
- Promotion of Skeletal Muscle Differentiation by K252a with Tyrosine Phosphorylation of Focal Adhesion: A Possible Involvement of Small GTPase RhoExperimental Cell Research, 1999
- Extracellular Signal-Regulated Kinase-1 and -2 Respond Differently to Mitogenic and Differentiative Signaling Pathways in MyoblastsMolecular Endocrinology, 1997
- Insulin Stimulates the Phosphorylation of the 66- and 52-Kilodalton Shc Isoforms by Distinct PathwaysEndocrinology, 1997
- The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling PathwaysJournal of Biological Chemistry, 1997
- Specific Increase in p85α Expression in Response to Dexamethasone Is Associated with Inhibition of Insulin-like Growth Factor-I Stimulated Phosphatidylinositol 3-Kinase Activity in Cultured Muscle CellsPublished by Elsevier ,1997
- Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.Journal of Clinical Investigation, 1995
- A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transductionCell, 1992